Loxo Oncology, Inc. Share-based Payment Arrangement, Expense
Loxo Oncology, Inc. reported Share-based Payment Arrangement, Expense of $11.15 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2018-11-08
- Loxo Oncology, Inc. share-based payment arrangement, expense for the quarter ending 2018-09-30 was $11.15M, a 111.71% increase year-over-year.
- Loxo Oncology, Inc. share-based payment arrangement, expense for the quarter ending 2018-06-30 was $12.35M, a 127.16% increase year-over-year.
- Loxo Oncology, Inc. share-based payment arrangement, expense for the quarter ending 2018-03-31 was $9.65M, a 142.85% increase year-over-year.
- Loxo Oncology, Inc. share-based payment arrangement, expense for the quarter ending 2017-12-31 was $4.75M.
- Loxo Oncology, Inc. share-based payment arrangement, expense for fiscal 2017 was $19.42M, a 143.99% increase from fiscal 2016.
- Loxo Oncology, Inc. share-based payment arrangement, expense for fiscal 2016 was $7.96M, a 29.35% increase from fiscal 2015.
- Loxo Oncology, Inc. share-based payment arrangement, expense for fiscal 2015 was $6.15M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2018-09-30 | $11.15M 10-Q · filed 2018-11-08 | $23.50M derived: sum of 2 quarters · filed 2018-11-08 | $33.15M 10-Q · filed 2018-11-08 | $37.90M derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | $12.35M 10-Q · filed 2018-08-09 | $22.00M 10-Q · filed 2018-08-09 | $26.74M derived: sum of 3 quarters · filed 2018-08-09 | $32.01M derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-03-31 | $9.65M 10-Q · filed 2018-05-08 | $14.40M derived: sum of 2 quarters · filed 2018-05-08 | $19.66M derived: sum of 3 quarters · filed 2018-11-08 | $25.10M derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-12-31 | $4.75M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $10.01M derived: sum of 2 quarters · filed 2018-11-08 | $15.45M derived: sum of 3 quarters · filed 2018-11-08 | $19.42M 10-K · filed 2018-03-01 |
| 2017-09-30 | $5.27M 10-Q · filed 2018-11-08 | $10.70M derived: sum of 2 quarters · filed 2018-11-08 | $14.68M 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $5.43M 10-Q · filed 2018-08-09 | $9.41M 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | $3.97M 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | $7.96M 10-K · filed 2018-03-01 | |||
| 2015-12-31 | $6.15M 10-K · filed 2018-03-01 |